Under CopyrightSchuhmacher, N.Reiß, T.Nusser, M.M.NusserTischendorf, A.A.Tischendorf2022-03-0722.05.20072006https://publica.fraunhofer.de/handle/publica/29292610.24406/publica-fhg-292926Preface S.3 Contents S.4-6 1 Introduction S.7-11 - 1.1 The Pharmaceutical Industry's Economic and Innovative Power S.7-8 - 1.2 Interviewed Companies: The International Research-Based Pharmaceutical Industry S.8-9 - 1.3 Methodology S.9-11 - Part 1: The Research-based International Pharmaceutical Industry as Important Economic Factor and Missed Employment Opportunities in Germany (Fraunhofer Gesellschaft) S.11 2 The Research-Based International Pharmaceutical Industry as an Important Economic Factor in Germany (Michael Nusser, Thomas Reiss, Philipp Seydel, Rainer Walz, Sven Wydra) S.12-21 - 2.1 Significance of the Research-Based Pharmaceutical Industry on the National Economy S.12-13 - 2.2 Direct and Indirect Employment Effects S.13-15 - 2.3 Jobs for Highly Qualified Employees S.16-20 - 2.3.1 Significance of Education and Qualifications on the National Economy, and Current Trends S.16-17 - 2.3.2 Highly Qualified Employees: Employment and Promotion S.17-19 - 2.3.3 Employment of Well-Trained Women S.19-20 - 2.4 Direct Contribution to Social Insurance Systems S.20-21 3 "Un-leveraged Opportunities" in the Pharmaceutical Industry - Missed Employment Potential in Germany (Michael Nusser, Thomas Reiss, Sven Wydra, Rainer Nägele) S.22-32 - 3.1 Un-leveraged Opportunities in Research and Development S.22-32 - 3.1.1 Significance of Research and Development on the National Economy S.22-23 - 3.1.2 Decreasing Significance of Germany as an R&D Location within the Pharmaceutical Industry S.23-26 - 3.1.3 The Pharmaceutical Industry as a Catalyst for Innovation S.26-28 - 3.1.4 Theoretical Employment Potential: Model Calculations for the ?Un-leveraged Opportunities? Scenario S.28-32 4 Summary of Part 1 Results S.33-34 - Part 2: Realizing Additional Employment Opportunities in Germany (A.T. Kearney) S.34 5 Germany's Significance to the International Pharmaceutical Industry S.35-50 - 5.1 Research and Development S.35-45 - 5.1.1 Significance of R&D and Current Trends S.35-38 - 5.1.2 Basic Research S.38-40 - 5.1.3 Clinical Development S.40-45 - 5.2 Production S.45-47 - 5.3 Marketing and Sales S.47-50 - Sidebar: Why Foreign Companies Choose to Invest in Germany S.48-50 6 Effective Policies to Promote Innovation S.51-63 - 6.1 Promoting the Research-Based Pharmaceutical Industry in Other Countries S.51-59 - 6.1.1 Established Countries S.51-55 - 6.1.2 Developing Countries S.55-59 - 6.2 Promoting Innovative Industries in Germany S.59-63 - 6.2.1 Optical Technologies S.59-61 - 6.2.2 Medical Engineering S.61-63 7 Conclusions S.64-69 - 7.1 Increasing Employment at Various Steps in the Pharmaceutical Industry S.64-65 - 7.2 Starting Points to Strengthen Clinical Research S.65-67 - 7.3 Future Employment Potential in Pharmaceutical R&D S.67-69 8 Summary of Results Part 2 S.70-71 9 Appendix S.72-83 - 9.1 Appendix 1: Description of the Fraunhofer ISIS Input-Output Model S.72-77 - 9.2 Appendix 2: Calculation of the Incorporated R&D S.78-83en303600study